Nizoral (Ketoconazole)

Ketoconazole in Nizoral is applied topically to manage superficial fungal infections of the skin.

• Tinea corporis: reduces lesion size and clears the fungal infection.
• Tinea cruris: alleviates itching and eliminates the causative dermatophyte.
• Tinea pedis: resolves scaling and erythema on the feet.
• Seborrheic dermatitis: diminishes flaking and redness on scalp and face.
• Pityriasis versicolor: restores normal skin pigmentation by eradicating Malassezia species.

• Ketoconazole inhibits the fungal enzyme lanosterol 14α‑demethylase, a key step in ergosterol synthesis. By blocking this pathway, the drug disrupts the formation of ergosterol, an essential component of fungal cell membranes, leading to increased membrane permeability and ultimately fungal cell death. The inhibition is concentration‑dependent and primarily affects dermatophytes and yeasts, while having minimal effect on human cells because humans do not synthesize ergosterol.

Topical ketoconazole may cause local skin reactions and, rarely, systemic adverse events.

Common Side Effects

• Irritation: mild burning, stinging, or tingling sensation at the site of application.
• Redness: localized erythema that may appear shortly after use.
• Itching: pruritus around the treated area, often transient.
• Dryness: skin dryness or flaking, sometimes accompanied by scaling.

Serious or Rare Side Effects

• Allergic reaction: swelling, widespread rash, or hives indicating hypersensitivity.
• Hepatotoxicity: rare systemic absorption that can cause elevated liver enzymes.
• Stevens‑Johnson syndrome: extremely rare severe mucocutaneous reaction requiring immediate medical attention.
• Severe skin irritation: ulceration, blistering, or necrosis at the application site.

When using topical ketoconazole, several precautions should be observed to ensure safety and effectiveness.

• Avoid use on broken skin: do not apply to open wounds or irritated areas.
• Limit duration: follow prescriber’s recommended treatment length, typically not exceeding 2‑4 weeks without review.
• Monitor for allergic signs: discontinue if rash, swelling, or severe itching develops.
• Caution in liver disease: although systemic absorption is low, patients with hepatic impairment should be evaluated.
• Pregnancy and lactation: safety not established; use only if benefit outweighs risk.
• Store at room temperature: keep in original container, protect from moisture and direct sunlight.

Topical ketoconazole has a limited systemic interaction profile, but certain concomitant agents may affect its safety or efficacy.

Major Interactions (Avoid)

• Systemic azoles: concurrent oral antifungal azoles may increase risk of systemic toxicity.
• CYP3A4 inhibitors: strong inhibitors could raise systemic ketoconazole levels if significant absorption occurs.

Moderate Interactions (Monitor Closely)

• Topical corticosteroids: may reduce antifungal effectiveness when used together.
• Skin irritants: co‑application with harsh soaps or chemicals can increase irritation.
• Phototoxic agents: use of photosensitizing drugs may heighten risk of sunburn on treated skin.